March 2019 - Page 23 of 25

TuesdayMar 05, 2019 8:30 am

QualityStocksNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Shallow Drilling Results Confirming Strong Mineralization

Canada-based exploration company Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) recently announced assay results from its ongoing 2019 drilling campaign at the Cyclops, Nickel/Cobalt Project Indonesia. According to the update, the results from 8 of the first 15 holes drilled in the Yapase area confirms the development of a complete mineralized laterite profile. In addition, results are starting to confirm grades and widths forming the basis of the project’s historical estimate. Surface mineralization occurs with elevated cobalt values of up to 0.24 percent encountered in the limonite layer, which is immediately underlain by the limonite transition and saprolite…

MondayMar 04, 2019 1:04 pm

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Expands Leadership Team

TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently announced the appointment of Arni Johannson as president. Johannson’s experience includes over 30 years operating and investing in both private and publicly traded companies throughout Canada and the U.S. During his career, he has been involved in numerous successful exits across multiple sectors and has served on more than 20 corporate boards. “Once we presented TransCanna's vision to Arni he immediately understood the potential, and agreed to not only be a director, but also President of the company,” TransCannna CEO Jim Pakulis said in the news release. “I firmly believe his operating knowledge…

MondayMar 04, 2019 12:46 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Conduct Clinical Studies on Oral Nicotine Delivery Utilizing DehydraTECH Absorption Platform

Lexaria Nicotine LLC, a subsidiary of Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), recently secured research and development (“R&D”) funding in exchange for equity and licensing rights. Utilizing its DehydraTECH absorption platform, Lexaria will execute a wide-ranging series of clinical studies on oral forms of nicotine delivery. A recent article discussing the company reads, “Under an investment agreement by its wholly owned subsidiary, Lexaria Nicotine LLC, a partner, will provide $1 million toward research on nicotine consumer products that use DehydraTECH(TM) (http://ibn.fm/9JkL7). . . . Lexaria’s partner will receive certain licensing rights to commercialize these DehydraTECH products exclusively in the United…

MondayMar 04, 2019 11:34 am

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) Secures Distribution Agreements in All 10 Canadian Provinces

Company recently signed letter of intent with the Société québécoise du cannabis Its production capacity is expected to increase by 170,000 lbs. through phase four Organigram’s growth plans expand beyond Canada and into the global cannabis market Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF), a licensed producer of cannabis and cannabis-derived products in Canada, recently announced that it has signed a letter of intent with the Société québécoise du cannabis (“SQDC”) (http://ibn.fm/eboHc). OGRMF’s wholly owned subsidiary, Organigram Inc., is focused on producing the highest quality, indoor-grown cannabis for recreational and condition-specific medical use. The new agreement with SQDC makes the company one…

MondayMar 04, 2019 11:12 am

Earth Science Tech Inc. (ETST) Positioned to ‘Catapult’ into 2019 as it Broadens Distribution, Expands CBD Sales Team

Under new distribution agreements, ETST is targeting new markets for its hemp CBD products Sales of cannabis-based pharmaceuticals are projected to account for 10 percent of the $31.6 billion legal cannabis market by 2022 ETST has expanded its sales team as it seeks product placement in health food stores and large chains Company-sponsored foundation recently achieved non-profit status to advance research on cannabinoids Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is looking to expand its cannabidiol (“CBD”) product distribution in wider markets in the United States. The company has reached agreements…

MondayMar 04, 2019 10:50 am

SinglePoint Inc.’s (SING) Solar and CBD Agreements Anticipate Booming Industry Profits

SinglePoint’s horizontally established portfolio is primed for exponential profit growth with the announcement of asset acquisition, capitalization plans The company’s plans to acquire solar energy business Direct Solar and solar marketer AI Live Transfers mark entry into industry eyeing $57.3 billion by 2022 Letter of intent anticipates raising up to $12 million to fund hemp-derived CBD opportunities amid projections of $22 billion market by 2022 SinglePoint is also investing in efforts to develop specific strains of CBD through the photobioreactor process Continued interest in energy systems that are friendly to the planet’s environment is creating new opportunity for exponential growth…

MondayMar 04, 2019 10:26 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Receives Equity Investment to Support Novel Immunotherapy Clinical Research

Proprietary targeted immunotherapy technology personalized to match unmet needs of advanced breast cancer patients Ongoing clinical studies of lead candidate, Bria-IMT, continue to show robust biological activity, excellent safety profile Breast cancer is one of the most commonly diagnosed cancers, with 2.1 million new cases expected in 2018 Global cancer immunotherapy market is projected to be valued at nearly $145 billion by 2022 An equity investment of C$500,000 into BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) by the company’s recently-appointed director, Jamieson Bondarenko (http://ibn.fm/okWzb), underscores the vital importance of BriaCell’s proprietary drug development efforts to millions of cancer patients. BriaCell is…

MondayMar 04, 2019 10:05 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Collaboration with The Steinbeis Centre

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments and platform technologies for the life sciences and other industries worldwide, today announced its entry into a collaboration with world-renowned German research organization The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry. The collaboration seeks to combine unique capabilities of PBIO's patented pressure cycling technology ("PCT") for sample preparation, protein characterization and biotherapeutics quality control with the Steinbeis Centre's innovative PROTEX-MS instrument for elucidating structural details of antibody interactions to create a novel instrument system designed to accelerate the development of new protein therapeutics…

MondayMar 04, 2019 9:51 am

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Announces Tenth Consecutive Quarter of Revenue Growth

Vancouver-based Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) this morning announced results from its fiscal second quarter, which marked its tenth consecutive quarter of revenue growth. Per the update, the company recorded Q2 sales of more than $1.4 million, up from $1 million in the first quarter. This increase was consistent across all sources, with the company’s largest sales growth stemming from sales to other retailers throughout the United States. To view the full press release, visit http://ibn.fm/x5Bet About Wildflower Brands Wildflower Brands is a company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects…

Site Search

Company Search

Month: March 2019